Correction: Sepsis-related immune signature C3 in endometrial carcinoma: implications for prognosis, tumor progression through bioinformatics and experimental validation
- PMID: 40526140
- DOI: 10.1007/s11033-025-10693-y
Correction: Sepsis-related immune signature C3 in endometrial carcinoma: implications for prognosis, tumor progression through bioinformatics and experimental validation
Erratum for
-
Sepsis-related immune signature C3 in endometrial carcinoma: implications for prognosis, tumor progression through bioinformatics and experimental validation.Mol Biol Rep. 2025 May 20;52(1):471. doi: 10.1007/s11033-025-10559-3. Mol Biol Rep. 2025. PMID: 40392380
Similar articles
-
Sepsis-related immune signature C3 in endometrial carcinoma: implications for prognosis, tumor progression through bioinformatics and experimental validation.Mol Biol Rep. 2025 May 20;52(1):471. doi: 10.1007/s11033-025-10559-3. Mol Biol Rep. 2025. PMID: 40392380
-
Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.Comb Chem High Throughput Screen. 2021;24(2):233-245. doi: 10.2174/1386207323999200729113641. Comb Chem High Throughput Screen. 2021. PMID: 32729416
-
Integrated bioinformatics analysis and experimental validation reveals fatty acid metabolism-related prognostic signature and immune responses for uterine corpus endometrial carcinoma.Front Oncol. 2022 Nov 9;12:1030246. doi: 10.3389/fonc.2022.1030246. eCollection 2022. Front Oncol. 2022. PMID: 36439473 Free PMC article.
-
Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma.Int J Biol Sci. 2021 Jan 1;17(2):448-459. doi: 10.7150/ijbs.51207. eCollection 2021. Int J Biol Sci. 2021. PMID: 33613104 Free PMC article.
-
Analysis of the Prognosis Prediction Ability of a Necroptosis-Related Gene Signature and its Relationship With the Hepatocellular Carcinoma Immune Microenvironment Using Bioinformatics Analysis and Experimental Validation.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231182208. doi: 10.1177/15330338231182208. Technol Cancer Res Treat. 2023. PMID: 37335078 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous